Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The dichotomies of 'typical/atypical' or 'first/second generation' have been employed for several decades to classify antipsychotics, but justification for their use is not clear. In the current analysis we argue that this classification is flawed from both clinical and pharmacological perspectives. We then consider what approach should ideally be employed in both clinical and research settings.

More information Original publication

DOI

10.1192/bjp.2023.131

Type

Journal article

Publication Date

2024-01-01T00:00:00+00:00

Volume

224

Pages

20 - 25

Total pages

5

Keywords

Schizophrenia, medication, nomenclature, pharmacology, psychosis, Humans, Antipsychotic Agents, Schizophrenia